1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ORC1 CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA ADAT2 CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA HCLS1 CTRPv2 pan-cancer AAC 0.2 0.0003
mRNA LMNB1 CTRPv2 pan-cancer AAC 0.2 4e-08
mRNA PROSER1 CTRPv2 pan-cancer AAC 0.2 5e-08
mRNA ARHGAP19 CTRPv2 pan-cancer AAC 0.21 4e-07
mRNA GMEB1 CTRPv2 pan-cancer AAC 0.21 2e-08
mRNA TAF5 CTRPv2 pan-cancer AAC 0.22 4e-09
mRNA MFNG CTRPv2 pan-cancer AAC 0.23 1e-06
mRNA EXOSC8 CTRPv2 pan-cancer AAC 0.24 9e-12
Download CSV